Till startsida
To content Read more about how we use cookies on gu.se

Marcus Lind

Marcus Lind presented his thesis in year 2009 at the University of Gothenburg focusing on evaluating effects of modern insulin analogues and HbA1c as a risk factor for diabetic complications. During his post-doc period he performed work at the Mid-America Heart Institute, Missouri University, US. Besides his research he has worked clinical as chief physician of Diabetology at the NU (NÄL and Uddevalla)-Hospital Group. He became Associate Professor of Diabetology year 2014 at the University of Gothenburg. He has performed essential research both in the epidemiologic field and clinical randomized trials which have been presented in New England Journal of Medicine, Lancet, JAMA and British Medical Journal. He has been in charge of over 40 studies.


  • Price for good scientific methodology and presentation at the "National meeting for physicians in Sweden in 2006"
  • Price as the “Diabetologist of the year” in Sweden in 2009 for research of metabolic memory and diabetic complications in the DCCT study.
  • Price for best diabetic publication in Sweden in 2011 regarding Heart Failure in Persons with Type 1 Diabetes. (Lind. M., Lancet, June, 2011).



Marcus Lind

Contact Information

Marcus Lind
Senior lecturer/ chief physician

Box 428, 40530 Gothenburg

Visiting Address:
Medicinaregatan 3, plan 5
413 90 Gothenburg

+46 31 82 39 25

Page Manager: Eva Sjögren Nilsson|Last update: 4/7/2017

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?